<DOC>
	<DOCNO>NCT02524899</DOCNO>
	<brief_summary>This study ass efficacy augment cognitive remediation therapy ( CRT ) pharmacological agent individual schizotypal personality disorder ( SPD ) . Impaired cognition , along functional social skill deficit , core feature schizophrenia schizophrenia spectrum disorder . A good understanding cognitive functional impairment schizophrenia-related condition , well identification intervention reduce impairment , vital improve outcome individual disorder .</brief_summary>
	<brief_title>CRT-Guanfacine SPD</brief_title>
	<detailed_description>This study propose 1 ) evaluate effect 7.5 week twice weekly cognitive remediation session , combine concurrent administration 8 week guanfacine/placebo , performance cognitive , functional , social skill performance measure sample SPD patient proven deficit area . 2 ) Compare effect cognitive remediation therapy + 8 week guanfacine cognitive remediation therapy + placebo cognition schizophrenia spectrum disorder population . 3 ) Further characterize cognitive impairment SPD use specific test work memory evaluate relationship work memory functional social skill outcomes population . The study hypothesize : 1 . While group ( receive CRT + guanfacine CRT +placebo ) demonstrate improvement overall cognitive functioning , SPD participant receive CRT + guanfacine evidence great increase post-treatment performance primary outcome measures—MATRICS battery total score , AX-CPT , N-Back , PASAT DOT Test— particularly area relate work memory . 2 . Participants receive CRT + guanfacine also demonstrate great improvement functional social function exploratory measure , evidence performance secondary assessment , UPSA , SSPA , MASC , Reading Mind Eyes .</detailed_description>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Schizotypal Personality Disorder</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Willing capacity provide inform consent Currently meeting DSMIVTR criterion Schizotypal Personality Disorder Males females age 1865 Medically healthy : major partially treat medical condition , base judgment clinician , would either put patient increase risk and/or affect finding . Neurologically healthy : brain injury head trauma associate loss consciousness , seizure , condition may cause functional impairment . At least two week free medication participate study Score least one standard deviation normative mean least one test cognitive battery . At least 2 week free psychotropic medication participate study . Medication NSAIDS ( e.g . Advil ) , Tylenol , Levothyroxine ( stable dose 1 month , symptoms hypothyroidism normal thyroid lab ) , noncentrally act antihistamine , H2 blocker ( e.g . Zantac ) , PPIs ( e.g . Prilosec , Prevacid ) , others impact cognitive functioning allow ; study physician evaluate medication time medical clearance case case basis . Meet criterion bipolar I disorder , schizophrenia , schizoaffective disorder , psychotic disorder Clinically significant cardiovascular neurological condition , uncontrolled hypertension , clinically significant EKG abnormality , serious general medial illness Current substance abuse meet criterion substance dependence within last 6 month ( exclude nicotine ) Currently meet DSMIVTR criterion Major Depressive Disorder , well account secondary personality disorder Currently take psychotropic medication Currently take medication ( systemic otherwise ) study physician determines could interfere study medication put participant risk and/or interfere data Currently pregnant lactate NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Schizotypal Personality Disorder</keyword>
	<keyword>SPD</keyword>
	<keyword>cognitive remediation therapy</keyword>
	<keyword>CRT</keyword>
	<keyword>guanfacine</keyword>
	<keyword>cognitive impairment</keyword>
	<keyword>work memory</keyword>
	<keyword>pharmacological cognitive enhancing agent</keyword>
	<keyword>neuropsychological testing</keyword>
	<keyword>schizophrenia spectrum disorder</keyword>
	<keyword>Personality Disorders</keyword>
</DOC>